Latest News

 Filter by Provider

What should investors do when data comes with warning labels?

Silver's explosive rally is grabbing headlines, but don't forget gold, which is also surging to record highs.

Which stocks have an unusual volume on Monday?

An interesting strategy: short one-month out-of-the-money (OTM) COST puts and calls to pay for longer-dated in-the-money (ITM) COST calls.

After several decades of falling birth rates and population aging, the US workforce growth has been slowing down. Future US economic growth will need to rely more heavily on higher productivity per hour–a change that is already underway.

Shares of WORK Medical are rising Monday after the company received manufacturing approval for one of its AI-powered products.

Lululemon founder Chip Wilson nominated three candidates for the company's board in an effort to reverse its dismal stock performance.

In an overvalued market, this artificial intelligence (AI) stock is trading at an incredibly low valuation relative to its earnings and is well-positioned to capitalize on the AI-driven memory shortage.

Natural gas is still up and down on weather reports and the perception of liquefied natural gas exports.

These companies pay lucrative dividends.

Sometimes, all that glitters really is gold.

Although the federal government shutdown has been over for a month and a half, most of the data that has been released has lagged badly, especially including data on sales, spending, and business orders.

The Santa Claus rally has faded to start the last week of 2025, as profit taking grips Wall Street.

These have both outperformed the S&P 500 over time.

Shares of Society Pass are rising Monday after the company announced the launch of a live commerce digital retail advertising platform.

Everyone's selling silver and gold today, but with Anglogold profits poised to surge 73%, selling today is probably a mistake.

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Claiming Social Security in 2026 is a big decision, but the data can be your guide.

Genmab will discontinue clinical development of acasunlimab to focus on more promising late-stage programs in its portfolio.

Billionaire Elon Musk said he cancelled his Netflix subscription in October. Musk is once again criticizing Netflix, this time taking on hit show "Stranger Things."

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Nutriband has agreed to sell 90% of its stake in its subsidiary Pocono Pharmaceuticals for $5 million.

March NY world sugar #11 (SBH26 ) today is up +0.09 (+0.59%). March London ICE white sugar #5 (SWH26 ) is down -1.20 (-0.28%). Sugar prices are mixed today, with NY sugar matching last Wednesday's 2.25-month high. Sugar prices have carryover suppor...

Investment firm Benchmark named video game publisher Take-Two Interactive as a "top idea" for 2026. TTWO stock is in a flat base.

You'll probably only recognize one of these names.

Investors seek magic formula, but markets need a combination. Value, momentum, trend, and credit work together for success. Credit is undervalued.

Honeywell stock is down 8% in 2025 and remains an attractive investment, given its majority stake in Quantinuum, a quantum computing company.

Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.

Silver and gold traders are selling, but at 21x earnings and with 50% growth, Barrick stock looks like a buy.

Strategy Inc. (NASDAQ:MSTR) has acquired another 1,229 BTC for $108.8 million at an average price of $88,568 per Bitcoin

US equities kicked off the final trading week of 2025 with a bit of a whimper, despite holding close to record highs. The truncated trading week will face a hiccup with a holiday closure on the cards later in the week.

TNXP announced updates on TNX-4800, a long-acting mAb targeting Lyme disease. Seeking FDA meeting in 2026.

March oats futures present a buying opportunity on more price strength.

The stock's rally appears to be a delayed reaction to significant operational updates earlier in the month.

As the final trading days of 2025 draw to a close, the financial world is shifting its gaze toward a milestone rarely seen in market history: a fourth consecutive year of gains for U.S. equities. With the S&P 500 (INDEXSP: .INX) having navigated the volatility of the mid-2020s

Agnico Eagle stock just got cheaper, but remains poised for 30%-plus earnings growth.